SleeperOne vs. Conventional Infiltration: Pain Perception in Mandibular Primary Molar Extraction
SOTIMAN
Comparative Evaluation of A Novel Anesthetic Device vs. Conventional Infiltration in Pain Perception Among A Group of Pediatric Patients Undergoing Extraction Of Mandibular Primary Molars: A Randomized Clinical Trial
1 other identifier
interventional
28
0 countries
N/A
Brief Summary
This clinical trial is being conducted in the Department of Pediatric Dentistry, Faculty of Dentistry, Cairo University. The purpose of the study is to compare the pain perception and comfort of children during tooth extraction when using a computer-controlled local anesthetic device (SleeperOne® 5) versus the conventional syringe infiltration technique. Children between 3 and 5 years of age who require extraction of a maxillary primary molar will be invited to participate. Before starting, a topical anesthetic gel (benzocaine) will be applied. Then, local anesthesia will be given using either the SleeperOne® device or the traditional syringe, depending on the group assigned. Pain during injection and extraction will be assessed using both child-friendly rating scales and independent evaluation by the dentist. Patient anxiety, heart rate, and blood pressure will also be recorded. This study aims to provide evidence on whether computer-controlled anesthesia can reduce children's pain and anxiety compared with the conventional method, leading to a more comfortable dental experience. The study is a randomized clinical trial and will be conducted in a single visit at the Pediatric Dentistry Outpatient Clinic, Faculty of Dentistry, Cairo University. The results may help improve pain management and patient comfort during dental treatment for children.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Sep 2025
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 8, 2025
CompletedStudy Start
First participant enrolled
September 2, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 2, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
September 2, 2025
CompletedFirst Posted
Study publicly available on registry
September 5, 2025
CompletedSeptember 5, 2025
July 1, 2025
Same day
August 8, 2025
September 2, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Pain during injection
Pain during injection will be assessed using the Sound-Eye-Motor (SEM) pain scale, which is a validated observational scale for evaluating pain response in pediatric patients. The SEM scale consists of three components-sound, eye, and motor reaction-each scored from 1 to 4, where a lower score indicates minimal or no pain and a higher score indicates greater discomfort. The total score is interpreted to reflect the child's behavioral reaction to the injection stimulus.
immediately during local anesthetic injection
Secondary Outcomes (4)
Patient anxiety
During injection and extraction in the same clinical visit
Heart rate changes
within 15 minutes after injection
Blood pressure changes
within 15 minutes after injection
Soft tissue injury
Within 24 hours after the procedure.
Study Arms (2)
Conventional Infiltration
ACTIVE COMPARATORChildren will receive 3% mepivacaine with conventional syringe after 20% benzocaine
SleeperOne® Device
EXPERIMENTALChildren will receive 3% mepivacaine using SleeperOne® device after 20% benzocaine.
Interventions
SleeperOne® is a computerized local anesthetic delivery system used to deliver 3% mepivacaine following application of 20% benzocaine topical gel. It is designed to reduce injection pain and improve comfort during pediatric dental procedures.
Local anesthetic (3% mepivacaine) will be administered using a conventional dental syringe after the application of 20% benzocaine topical anesthetic.
Eligibility Criteria
You may qualify if:
- Children Aged between 3 to 5 years.
- Medically fit children classified as ASA physical status I and II
- Parents acceptance to participate in the study (informed consent)
- Children with teeth diagnostically confirmed to require extraction
You may not qualify if:
- Patients with an allergy to local anesthesia.
- Uncooperative children
- Children requiring general anesthesia
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Ameera Alaa ElDin, MSc Candidate in Pediatric Den
CONTACT
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- MSc Candidate in Pediatric Dentistry, Faculty of Dentistry, Cairo University
Study Record Dates
First Submitted
August 8, 2025
First Posted
September 5, 2025
Study Start
September 2, 2025
Primary Completion
September 2, 2025
Study Completion
September 2, 2025
Last Updated
September 5, 2025
Record last verified: 2025-07
Data Sharing
- IPD Sharing
- Will not share
Individual participant data (IPD) will not be shared because this is a student-initiated academic trial, and data confidentiality will be maintained in accordance with ethical standards.